top of page

Home
Our Platform
Our Results
About Us
Contact Us
News
More

Use tab to navigate through the menu items.

< Back

PolygenRx founders receive $7 million in funding to support their clinical and pre-clinical precision medicine research program

20 Dec 2023

contact@polygenrx.com

Newcastle, NSW, Australia

Keywords: PolygenRx; precision medicine; companion diagnostics; targeted therapy; polygenic architecture; drug development, drug discovery; drug repurposing; pharmaceuticals; chronic disease; genetics; pharmagenic enrichment score (PES).

© 2022 PolygenRX

Website design and development by Rosalie Grierson-Burgess

Connect With Us On:

bottom of page